Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET. - Wikidata - awgldk - TriplyDB

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

http://www.wikidata.org/entity/Q37346559

about

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate.

P2860

Q37688459-BB22EEE0-0B9D-41EB-AC28-0FE1791F6B1F Q37735662-F43DAF09-5E3A-4D65-AE96-D12C74A11B88 Q41705524-67D9E044-9131-4E52-A894-1E8819E1414A

P2860

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

http://www.wikidata.org/entity/Q37346559

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@en

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@nl

type

label

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@en

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@nl

prefLabel

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@en

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@nl

P1433

Q37346559-56101C6F-4154-4954-AB71-B85BC75BAD72

P1476

Q37346559-446ED9AD-7E6A-4779-B9C8-2FFE7625F556

P2093

Q37346559-0041E8C6-CCB8-4A9C-8B07-BC7C6BF7CB39

Q37346559-0ED06387-C1D6-4A09-AF38-EB270AF53E0C

Q37346559-12AAF18B-228D-4CE8-8A69-22B1F03B323D

Q37346559-228536A7-4732-4D4B-A9A4-0F37024CE284

Q37346559-2BFD2C5A-F248-4C33-8C1B-67A04003C922

Q37346559-31C4EF98-BBC8-45C6-B36B-3E9BCD6F13D4

Q37346559-4677020A-DB50-4123-AFB9-1E18A10B2DA6

Q37346559-618646DF-C51C-4E0D-B74F-FAD87C63602B

Q37346559-7F44711E-CD8E-41FE-8AE4-3802CFB30616

Q37346559-80CA6CA0-0D94-4228-A95C-8ABFFE69EE4D

P2860

Q37346559-044A7BA6-078B-4BD6-AF28-C9A284490A7C

Q37346559-0E789BE6-AF72-4B8B-B789-3D6DB43545B2

Q37346559-1322BA98-813C-455E-AEAD-9F24325530EB

Q37346559-19561365-8050-45D2-B4E8-AF6970CBC50C

Q37346559-210EC6C8-072A-41C6-9AA9-E97788B8B030

Q37346559-2AC11182-908B-427F-812E-A03774B31218

Q37346559-2B161320-D19D-4C7E-A9E8-69473058A007

Q37346559-3BE4864B-21D8-440B-85D4-9017D4AF666A

Q37346559-3C9531A7-3381-45F1-BA1C-B0E127A2715F

Q37346559-3EFFEDBB-0743-4048-A256-AD7A1FB5482E

P304

Q37346559-3CD6FBAE-1C54-4649-8C54-695876974742

P31

Q37346559-3F0ADC9E-B71E-4F83-B20A-710E99418A1E

P356

Q37346559-DBDDD575-2DFA-4C91-82DB-5D68E01BFFCB

P433

Q37346559-C2AAAFCB-282C-49FB-AAE5-8B3F6662A445

P478

Q37346559-FF6E5BC2-ABD9-44AB-8E95-4A102FDF5558

P577

Q37346559-3F7ED500-6CD2-44C2-B1F2-AE7ED26B05FA

P698

Q37346559-FAE7C112-A0CC-46EC-AB3F-36C69EA0269C

P932

Q37346559-EB7458AE-3ADA-4CA1-A4D7-BA52C2381A86

P356

P1433

The journal of pathology. Clinical research

P1476

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET.

@en

P2093

Alberto M Marchevsky

http://www.w3.org/2001/XMLSchema#string

Ann E Walts

http://www.w3.org/2001/XMLSchema#string

Arkadiusz Gertych

http://www.w3.org/2001/XMLSchema#string

Beatrice S Knudsen

http://www.w3.org/2001/XMLSchema#string

Benjamin Berman

http://www.w3.org/2001/XMLSchema#string

Daniel J Luthringer

http://www.w3.org/2001/XMLSchema#string

Deepti Dhall

http://www.w3.org/2001/XMLSchema#string

Fangjin Huang

http://www.w3.org/2001/XMLSchema#string

George Vande Woude

http://www.w3.org/2001/XMLSchema#string

Jayati Mallick

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements

Thirty years of research on met receptor to move a biomarker from bench to bedside

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

Met, metastasis, motility and more

Comprehensive molecular profiling of lung adenocarcinoma.

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method

ROCR: visualizing classifier performance in R

limma powers differential expression analyses for RNA-sequencing and microarray studies

Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.

MaizeGDB update: new tools, data and interface for the maize model organism database

P304

210-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CJP2.49

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27785366

http://www.w3.org/2001/XMLSchema#string

P932

5068192

http://www.w3.org/2001/XMLSchema#string